KISS1 and endometriosis: These findings could inspire the development of pharmacological agents aimed at normalizing kisspeptin signaling, ultimately enhancing outcomes and quality of life for patients with endometriosis by targeting both systemic and local tissue effects of this pathway, with promising implications for future therapies.